Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 10, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	5,698	4,465	3,043	2,939	2,601	1,828
Market Cap Growth	46.74%	46.74%	3.52%	13.02%	42.23%	25.34%
Enterprise Value	5,506	3,709	2,488	2,474	2,149	1,172
Last Close Price	1291.20	998.56	668.58	633.75	526.89	363.00
PE Ratio	17.77	13.93	11.71	11.95	11.66	11.08
PS Ratio	3.76	2.94	2.14	2.15	2.10	1.67
PB Ratio	3.32	2.60	2.10	2.40	2.22	1.86
P/TBV Ratio	3.32	2.60	2.11	2.40	2.22	1.87
P/FCF Ratio	69.56	54.50	54.63	19.66	41.83	9.99
P/OCF Ratio	20.42	16.00	37.46	17.24	28.05	9.40
EV/Sales Ratio	3.63	2.44	1.75	1.81	1.73	1.07
EV/EBITDA Ratio	13.69	9.33	7.67	8.28	8.04	6.15
EV/EBIT Ratio	14.61	9.84	8.08	8.78	8.45	6.58
EV/FCF Ratio	67.21	45.28	44.68	16.55	34.56	6.40
Debt / Equity Ratio	0.02	0.02	-	0.02	0.06	0.05
Debt / EBITDA Ratio	0.10	0.10	-	0.10	0.25	0.26
Debt / FCF Ratio	0.48	0.48	-	0.20	1.09	0.28
Asset Turnover	0.84	0.84	0.93	0.96	0.94	0.97
Inventory Turnover	3.53	3.53	3.71	3.71	3.67	3.32
Quick Ratio	2.39	2.39	6.01	4.48	3.00	3.91
Current Ratio	3.00	3.00	6.70	5.15	3.57	4.45
Return on Equity (ROE)	20.25%	20.25%	19.43%	20.52%	20.66%	18.49%
Return on Assets (ROA)	13.04%	13.04%	12.54%	12.37%	12.04%	9.87%
Return on Capital (ROIC)	14.69%	14.69%	14.24%	14.12%	13.97%	11.80%
Return on Capital Employed (ROCE)	21.20%	21.20%	20.70%	22.40%	20.90%	17.30%
Earnings Yield	5.63%	7.18%	8.54%	8.37%	8.57%	9.03%
FCF Yield	1.44%	1.84%	1.83%	5.08%	2.39%	10.01%
Dividend Yield	1.39%	1.80%	2.29%	2.27%	2.28%	2.81%
Payout Ratio	21.15%	21.15%	24.32%	22.35%	20.99%	-
Buyback Yield / Dilution	-	-	3.34%	0.52%	-	-
Total Shareholder Return	1.38%	1.80%	5.63%	2.79%	2.28%	2.81%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.